Venous thromboembolism (VTE) is a common complication among patients in the intensive care unit. While anticoagulation remains standard therapy, vena caval filters are an important alternative when anticoagulation is contraindicated. To determine the safety and efficacy of vena caval filters in the treatment of VTE, a comprehensive review of the English-language medical literature was performed. Except for one randomized controlled trial, the literature supporting the use of vena caval filters consists almost exclusively of case series, which in many instances are limited by incomplete and short follow-up. While case series suggest that filters function effectively in the prevention of pulmonary embolism (2%-4% symptomatic pulmonary embolism [PE], fatal PE < 2%), recent higher quality studies indicate that filters may not provide significant additional protection to that provided by anticoagulation alone. Furthermore, filters are associated with a 2- fold increase in the incidence of recurrent DVT. Until randomized comparative studies are available, the safety and efficacy of all the available devices should be considered to be roughly equivalent. Since filters do not inhibit continued clot formation, all filter patients should receive anticoagulation for durations appropriate for their thrombotic disorder. Although extended anticoagulation may prevent thrombotic complications associated with filter placement, this strategy has yet to be experimentally tested. While many additional indications for vena caval filter use have been proposed (VTE in cancer patients, PE prophylaxis in trauma patients, etc), well-designed clinical trials demonstrating their efficacy in these situations are lacking. Further development of temporary/retrievable filters, which offer the potential to avoid the long-term complications of permanent filters, should be a research priority. Until additional data are available, vena caval filters should generally be restricted to patients with VTE who cannot receive anticoagulation.
Get full access to this article
View all access options for this article.
References
1.
1. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ III. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998; 158(6): 585-593.
2.
2. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991; 151(5): 933-938.
3.
3. Marik PE, Andrews L, Maini B. The incidence of deep venous thrombosis in ICU patients. Chest. 1997; 111(3): 661-664.
4.
4. Hirsch DR, Ingenito EP, Goldhaber SZ. Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA. 1995; 274(4): 335-337.
5.
5. Greenfield LJ, McCurdy JR, Brown PP, Elkins RC. A new intracaval filter permitting continued flow and resolution of emboli. Surgery. 1973; 73: 599-606.
6.
6. Jones TK, Barnes RW, Greenfield LJ. Greenfield vena caval filter: rationale and current indications. Ann Thorac Surg. 1986; 42(6 Suppl): S48-S55.
7.
7. Greenfield L, DeLucia A. Endovascular therapy of venous thromboembolic disease. Surg Clin North Am. 1992; 72: 969-989.
8.
8. Millward SF, Marsh JI, Peterson RA, et al. LGM (Vena Tech) vena cava filter: clinical experience in 64 patients [see Comments]. J Vasc Interv Radiol. 1991; 2(4): 429-433.
9.
9. Taylor FC, Awh MH, Kahn CE Jr, Lu CT. Vena tech vena cava filter: experience and early follow-up [see Comments]. J Vasc Interv Radiol. 1991; 2(4): 435-440.
10.
10. Simon M, Athanasoulis CA, Kim D, et al. Simon Nitinol inferior vena cava filter: initial clinical experience. Work in progress. Radiology. 1989; 172(1): 99-103.
11.
11. Rousseau H, Perreault P, Otal P, et al. The 6-F Nitinol TrapEase inferior vena cava filter: results of a prospective multicenter trial. J Vasc Interv Radiol. 2001; 12(3): 299-304.
12.
12. Roehm JO Jr, Johnsrude IS, Barth MH, Gianturco C. The bird’s nest inferior vena cava filter: progress report. Radiology. 1988; 168(3): 745-749.
13.
13. Martin B, Martyak TE, Stoughton TL, Collazo WA, Pearl W. Experience with the Gianturco-Roehm bird’s nest vena cava filter. Am J Cardiol. 1990; 66(17): 1275-1277.
14.
14. Wingerd M, Bernhard VM, Maddison F, Towne JB. Comparison of caval filters in the management of venous thromboembolism. Arch Surg. 1978; 113: 1264-1271.
15.
15. Berland LL, Maddison FE, Bernhard VM. Radiologic follow-up of vena cava filter devices. AJR. Am J Roentgenol. 1980; 134: 1047-1052.
16.
16. Cimochowski GE, Evans RH, Zarins CK, Lu CT, DeMeester TR. Greenfield filter versus Mobin-Uddin umbrella: the continuing quest for the ideal method of vena caval interruption. J Thorac Cardiovasc Surg. 1980; 79(3): 358-365.
17.
17. Greenfield LJ, Peyton R, Crute S, Barnes R. Greenfield vena caval filter experience: late results in 156 patients. Arch Surg. 1981; 116: 1451-1456.
18.
18. Stewart JR, Peyton JWR, Crute S, Greenfield LJ. Clinical results of suprarenal placement of the Greenfield vena cava filter. Surgery. 1982; 92: 1-4.
19.
19. Gomez GA, Cutler BS, Wheeler HB. Transvenous interruption of the inferior vena cava. Surgery. 1983; 93: 612-619.
20.
20. Scurr JH, Jarrett PEM, Wastell C. The treatment of recurrent pulmonary embolism: experience with the Kimray-Greenfield vena cava filter. Ann R Coll Surg Engl. 1983; 65: 233-234.
21.
21. Orsini RA, Jarrell BE. Suprarenal placement of vena caval filters: indications, techniques and results. J Vasc Surg. 1984; 1: 124-135.
22.
22. Hux CH, Wapner RJ, Chayen B, Rattan P, Jarrell B, Greenfield L. Use of the Greenfield filter for thromboembolic disease in pregnancy. Am J Obstet Gynecol. 1986; 155(4): 734-737.
23.
23. Carabasi RA, Moritz MJ, Jarrell BE. Complications encountered with the use of the Greenfield filter. Am J Surg. 1987; 154: 163-168.
24.
24. Rose BS, Simon DC, Hess ML, Van Aman ME. Percutaneous transfemoral placement of the Kimray-Greenfield vena cava filter. Radiology. 1987; 165: 373-376.
25.
25. Golueke PJ, Garrett WV, Thompson JE, Smith BL, Talkington CM. Interruption of the vena cava by means of the Greenfield filter: expanding the indications. Surgery. 1988; 103(1): 111-117.
26.
26. Greenfield LJ, Michna BA. Twelve-year clinical experience with the Greenfield vena caval filter. Surgery. 1988; 104: 706-712.
27.
27. Pais SO, Tobin KD, Austin CB, Queral L. Percutaneous insertion of the Greenfield inferior vena cava filter: experience with ninety-six patients. J Vasc Surg. 1988; 8: 460-464.
28.
28. Todd GJ, Sanderson J, Nowygrod R, Benvenisty A, Reemtsma K. Recent clinical experience with the vena cava filter. Am J Surg. 1988; 156: 353-358.
29.
29. Welch TJ, Stanson AW, Sheedy PF II, et al. Percutaneous placement of the Greenfield vena caval filter. Mayo Clin Proc. 1988; 63: 343-347.
30.
30. Jones B, Fink JA, Donovan DL, Sharp WV. Analysis of benefit of anticoagulation after placement of Kimray-Greenfield filter. Surg Gynecol Obstet. 1989; 169: 400-402.
31.
31. Richenbacher WE, Atnip RG, Campbell DB, Waldhausen JA. Recurrent pulmonary embolism after inferior vena caval interruption with a Greenfield filter. World J Surg. 1989; 13(5): 623-628.
32.
32. Rohrer MJ, Scheidler MG, Wheeler HB, Cutler BS. Extended indications for placement of an inferior vena cava filter [see Comments]. J Vasc Surg. 1989; 10(1): 44-49.
33.
33. Hye RJ, Mitchell AT, Dory CE, Freischlag JA, Roberts AC. Analysis of the transition to percutaneous placement of Greenfield filters. Arch Surg. 1990; 125(12): 1550-1553.
35. Fink JA, Jones BT. The Greenfield filter as the primary means of therapy in venous thromboembolic disease. Surg Gynecol Obstet. 1991; 172(4): 253-256.
36.
36. Hlavaty TS, McCowan TC, Ferris EJ, Carver DL, Barnes RW. Experience with the Kimray-Greenfield inferior vena caval filter. J Ark Med Soc. 1991; 88: 215-217.
37.
37. Pomper SR, Lutchman G. The role of intracaval filters in patients with COPD and DVT. Angiology. 1991; 42(2): 85-89.
38.
38. Braverman SJ, Battey PM, Smith RB. Vena caval interruption. Am Surg. 1992; 58: 188-192.
39.
39. Lang W, Schweiger H, Hofmann-Preiss K. Results of longterm venacavography study after placement of a Greenfield vena caval filter. J Cardiovasc Surg. 1992; 33: 573-578.
40.
40. Magnant JG, Walsh DB, Juravsky LI, Cronenwett JL. Current use of inferior vena cava filters. J Vasc Surg. 1992; 16(5): 701-706.
41.
41. Alexander JJ, Yuhas JP, Piotrowski JJ. Is the increasing use of prophylactic percutaneous IVC filters justified? Am J Surg. 1994; 168: 102-106.
42.
42. Jones BT, Fink JA. A prospective comparison of the status of the deep venous system after treatment with intracaval interruption versus anticoagulation. J Am Coll Surg. 1994; 178(3): 220-222.
43.
43. Sullivan TM, Martinez BD, Lemmon G, Clark PM, Schwartz RA, Bondy B. Clinical experience with the Greenfield filter in 193 patients and description of a new technique for operative insertion [see Comments]. J Am Coll Surg. 1994; 178(2): 117-122.
44.
44. Greenfield LJ, Proctor MC. Twenty-year clinical experience with the Greenfield filter. Cardiovasc Surg. 1995; 3(2): 199-205.
45.
45. Mohan CR, Hoballah JJ, Sharp WJ, Kresowik TF, Lu CT, Corson JD. Comparative efficacy and complications of vena caval filters. J Vasc Surg. 1995; 21(2): 235-245.
46.
46. Ortega M, Gahtan V, Roberts A, Matsumoto T, Kerstein M. Efficacy of anticoagulation post-inferior vena caval filter placement. Am Surg. 1998; 64(5): 419-423.
47.
47. Greenfield LJ, Cho KJ, Proctor MC, et al. Results of a multicenter study of the modified-hook titanium Greenfield filter. J Vasc Surg. 1991; 14: 253-257.
48.
Published Erratum Appears in J Vasc Surg1995 Jan; 21(1): 162.
49.
49. Harris EJ Jr, Kinney EV, Harris EJS, Olcott C, Zarins CK. Phlegmasia complicating prophylactic percutaneous inferior vena caval interruption: a word of caution. J Vasc Surg. 1995; 22(5): 606-611.
50.
50. Thomas LA, Summers RR, Cardwell MS. Use of Greenfield filters in pregnant women at risk for pulmonary embolism. South Med J. 1997; 90: 215-217.
51.
51. Wittenberg G, Kueppers V, Tschammler A, et al. Long-term results of vena cava filters: experiences with the LGM and the titanium Greenfield devices. Cardiovasc Intervent Radiol. 1998; 21: 225-229.
52.
52. Athanasoulis CA, Kaufman JA, Halpern EF, Wlatman AC, Geller SC, Fan C-M. Inferior vena caval filters: review of a 26 year single center clinical experience. Radiology. 2000; 216(1): 54-66.
53.
53. Ferris EJ, McCowan TC, Carver DK, McFarland D. Percutaneous inferior vena caval filters: follow up of seven designs in 320 patients. Radiology. 1993; 188: 851-856.
54.
54. Cho KJ, Greenfield LJ, Proctor MC, et al. Evaluation of a new percutaneous stainless steel Greenfield filter. J Vasc Intervent Radiol. 1997; 8(2): 181-187.
55.
55. Johnson SP, Raiken DP, Grebe PJ, Diffin DC, Leyendecker JR. Single institution prospective evaluation of the over-the-wire Greenfield vena caval filter. J Vasc Interv Radiol. 1998; 9(5): 766-773.
56.
56. Greenfield LJ, Proctor MC. The percutaneous Greenfield filter: outcomes and practice patterns. J Vasc Surg. 2000; 32(5): 888-893.
57.
57. Smith JA, Atkinson NR, Walters NA, Thomson KR. Early experience with the bird’s nest inferior vena-caval filter [Letter]. Med J Aust. 1989; 150(3): 164-165.
58.
58. Lord RS, Benn I. Early and late results after bird’s nest filter placement in the inferior vena cava: clinical and duplex ultrasound follow up. Aust N Z J Surg. 1994; 64(2): 106-114.
59.
59. Starok MS, Common AA. Follow-up after insertion of bird’s nest inferior vena caval filters. Can Assoc Radiol J. 1996; 47(3): 189-194.
60.
60. Young N. Clinical follow-up of patients with percutaneously inserted inferior vena caval filters. Australas Radiol. 1995; 39(3): 233-236.
61.
61. Wojtowycz MM, Stoehr T, Crummy AB, McDermott JC, Sproat IA. The bird’s nest inferior vena caval filter: review of a single-center experience. J Vasc Interv Radiol. 1997; 8(2): 171-179.
62.
62. Thomas JH, Cornell KM, Siegel EL, Sparks C, Rosenthal SJ. Vena caval occlusion after bird’s nest filter placement. Am J Surg. 1998; 176(6): 598-600.
63.
63. Reed RA, Teitelbaum GP, Taylor FC, Pentecost MJ, Roehm JO. Use of the bird’s nest filter in oversized inferior venae cavae. J Vasc Intervent Radiol. 1991; 2(4): 447-450.
64.
64. Ricco JB, Crochet D, Sebilotte P, et al. Percutaneous transvenous caval interruption with the LGM filter: early results of a multicenter trial. Ann Vasc Surg. 1988; 3: 242-247.
65.
65. Cull DL, Wheeler JR, Gregory RT, Synder SO Jr, Gayle RG, Parent FN. The vena tech filter: evaluation of a new inferior vena cava interruption device. J Cardiovasc Surg. 1991; 32(5): 691-696.
66.
66. Murphy TP, Dorfman GS, Yedlicka JW, et al. LGM vena cava filter: objective evaluation of early results. J Vasc Interv Radiol. 1991; 2(1): 107-115.
67.
67. Crochet DP, Stora O, Ferry D, et al. Vena tech-LGM filter: long-term results of a prospective study. Radiology. 1993; 188(3): 857-860.
68.
68. Millward SF, Peterson RA, Moher D, et al. LGM (Vena Tech) vena caval filter: experience at a single institution. J Vasc Interv Radiol. 1994; 5(2): 351-356.
69.
69. Ricco JB, Dubreuil F, Reynaud P, et al. The LGM vena-tech caval filter: results of a multicenter study. Ann Vasc Surg. 1995;9 Suppl: S89-S100: S89-S100.
70.
70. Crochet DP, Brunel P, Trogrlic S, Grossetete R, Auget JL, Dary C. Long-term follow-up of vena tech-LGM filter: predictors and frequency of caval occlusion [in Process Citation]. J Vasc Interv Radiol. 1999; 10(2 Pt 1): 137-142.
71.
71. Grassi CJ, Matsumoto AH, Teitelbaum GP. Vena caval occlusion after Simon Nitinol filter placement: identification with MR imaging in patients with malignancy. J Vasc Interv Radiol. 1992; 3(3): 535-539.
72.
72. Hawkins SP, al-Kutoubi A. The Simon Nitinol inferior vena cava filter: preliminary experience in the UK. Clin Radiol. 1992; 46(6): 378-380.
73.
73. Kim D, Edelman RR, Margolin CJ, et al. The Simon Nitinol filter: evaluation by MR and ultrasound. Angiology. 1992; 43(7): 541-548.
75. Engmann E, Asch M. Clinical experience with the antecubital Simon Nitinol IVC filter. J Vasc Interv Radiol. 1998; 9(5): 774-778.
76.
76. Poletti PA, Becker CD, Prina L, et al. Long-term results of the Simon Nitinol inferior vena cava filter. Eur Radiol. 1998; 8(2): 289-294.
77.
77. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention Du Risque D’Embolie Pulmonaire Par Interruption Cave Study Group [see Comments]. N Engl J Med. 1998; 338(7): 409-415.
78.
78. White RH, Zhou H, Kim J, Romano PS. A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism. Arch Intern Med. 2000; 160(13): 2033-2041.
79.
79. Kantor A, Glanz S, Gordon DH, Sclafani SJA. Percutaneous insertion of the Kimray-Greenfield filter: incidence of femoral vein thrombosis. AJR. Am J Roentgenol. 1987; 149: 1065-1066.
80.
80. Mansour M, Chang AE, Sindelar WF. Interruption of the inferior vena cava for the prevention of recurrent pulmonary embolism. Am Surg. 1985; 51: 375-380.
81.
81. Heit JA, Rooke TW, Silverstein MD, et al. Trends in the incidence of venous stasis syndrome and venous ulcer: a 25- year population-based study. J Vasc Surg. 2001; 33(5): 1022-1027.
82.
82. Prandoni P, Villalta S, Bagatella P, et al. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica. 1997; 82(4): 423-428.
83.
83. Bianchini AU, Mehta SN, Mulder DS, Barkun AN, Mayrand S. Duodenal perforation by a Greenfield filter: endoscopic diagnosis. Am J Gastroenterol. 1997; 92(4): 686-687.
84.
84. Dabbagh A, Chakfe N, Kretz JG, et al. Late complication of a Greenfield filter associating caudal migration and perforation of the abdominal aorta by a ruptured strut. J Vasc Surg. 1995; 22(2): 182-187.
85.
85. Goldman HB, Hanna K, Dmochowski RR. Ureteral injury secondary to an inferior vena caval filter. J Urol. 1996; 156(5): 17-63.
89. McAuley CE, Webster MW, Jarrett F, Hirsch SA, Steed DL. The Greenfield intracaval filter as a source of recurrent pulmonary thromboembolism. Surgery. 1984; 96(3): 574-577.
90.
90. Geisinger MA, Zelch MG, Risius B. Recurrent pulmonary embolism after Greenfield filter placement. Radiology. 1987; 165(2): 383-384.
91.
91. Feinman LJ, Meltzer AJ. Phlegmasia cerulea dolens as a complication of percutaneous insertion of a vena caval filter. J Am Osteopath Assoc. 1989; 89(1): 63-68.
92.
92. Lee HC, Laya MB. Lethal pulmonary embolism in a patient with primary antiphospholipid syndrome and a vena caval filter. Chest. 1994; 105(1): 312-313.
93.
93. Sack GH, Levin J, Bell WR. Trousseau’s syndrome and other manifestations of chronic disemminated coagulopathy in patients with neoplasms: clinical, pathophysiological and therapeutic features. Medicine. 1977; 56: 1-37.
94.
94. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med. 2001; 344(16): 1222-1231.
95.
95. Kearon C, Crowther M, Hirsh J. Management of patients with hereditary hypercoagulable disorders. Annu Rev Med. 2000; 51: 169-185.
96.
96. Kyrle PA, Minar E, Hirschl M, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med. 2000; 343(7): 457-462.
97.
97. Greenfield LJ, Proctor MC. Recurrent thromboembolism in patients with vena cava filters. J Vasc Surg. 2001; 33(3): 510-514.
98.
98. Teitelbaum GP, Bradley WG Jr, Klein BD. MR imaging artifacts, ferromagnetism, and magnetic torque of intravascular filters, stents, and coils. Radiology. 1988; 166(3): 657-664.
99.
99. Watanabe AT, Teitelbaum GP, Gomes AS, Roehm JO Jr. MR imaging of the bird’s nest filter. Radiology. 1990; 177(2): 578-579.
101. Kiproff PM, Deeb ZL, Contractor FM, Khoury MB. Magnetic resonance characteristics of the LGM vena cava filter: technical note. Cardiovasc Intervent Radiol. 1991; 14(4): 254-255.
102.
102. Dardik A, Campbell KA, Yeo CJ, Lipsett PA. Vena cava filter ensnarement and delayed migration: an unusual series of cases. J Vasc Surg. 1997; 26(5): 869-874.
103.
103. Andrews RT, Geschwind JF, Savader SJ, Venbrux AC. Entrapment of J-tip guidewires by venatech and stainlesssteel Greenfield vena cava filters during central venous catheter placement: percutaneous management in four patients. Cardiovasc Intervent Radiol. 1998; 21(5): 424-428.
104.
104. Drummond JC, Spaeth JP, Dharan M. The IJ guide-wire is “stuck.” Anesthesiology. 1997; 86(3): 745-746.
105.
105. Amesbury S, Vargish T, Hall J. An unusual complication of central venous catheterization. Chest. 1995; 107(1): 296.
106.
106. Marelich GP, Tharratt RS. Greenfield inferior vena cava filter dislodged during central venous catheter placement. Chest. 1994; 106(3): 957-959.
107.
107. Rosenblum JD, Boyle CM. Percutaneous retrieval of a vena-tech filter displaced during central line placement. AJR. Am J Roentgenol. 1996; 166(4): 994-995.
108.
108. Johnson D, Harshfield D. Radiological case of the month. Inadvertant guidewire entrapment by IVC filter during subclavian line placement. J Ark Med Soc. 1993; 89(10): 517-518.
109.
109. Gibson MP, Chung RS, Husni EA, Kuivinen EP. Dislodgment and entrapment of a Greenfield filter. J Vasc Intervent Radiol. 1999; 10(3): 378-379.
111. Streib EW, Wagner JW. Complications of vascular access procedures in patients with vena cava filters. J Trauma. 2000; 49(3): 553-557.
112.
112. Urbaneja A, Fontaine AB, Bruckner M, Spigos DG. Evulsion of a vena tech filter during insertion of a central venous catheter. J Vasc Interv Radiol. 1994; 5(5): 783-785.
113.
113. Morgan JT, Sussman SK. “Monorail technique” for removal of entrapped exchange wire in a Greenfield filter. J Vasc Interv Radiol. 1998; 9(3): 469-470.
114.
114. Arpasi P, Kirsch MJ. Dislodgment of a stainless-steel Greenfield filter during exchange of a central venous catheter [Letter]. J Vasc Intervent Radiol. 1997; 8(6): 1080-1082.
115.
115. Loesberg A, Taylor FC, Awh MH. Dislodgment of inferior vena caval filters during “blind” insertion of central venous catheters. AJR. Am J Roentgenol. 1993; 161(3): 637-638.
116.
116. Argiris A, Rademaker J, Mahmud M. Dislodgment of an inferior vena cava filter to the internal jugular vein. Intensive Care Med. 1997; 23(11): 1186-1187.
117.
117. Kaufman JA, Thomas JW, Geller SC, Rivitz SM, Waltman AC. Guide-wire entrapment by inferior vena caval filters: in vitro evaluation. Radiology. 1996; 198(1): 71-76.
118.
118. Andrews RT, Bova DA, Venbrux AC. How much guidewire is too much? Direct measurement of the distance from subclavian and internal jugular vein access sites to the superior vena cava-atrial junction during central venous catheter placement. Crit Care Med. 2000; 28(1): 138-142.
119.
119. Brenner DW, Brenner CJ, Scott J, Wehberg K, Granger JP, Schellhammer PF. Suprarenal Greenfield filter placement to prevent pulmonary embolus in patients with vena caval tumor thrombi. J Urol. 1992; 147(1): 19-23.
120.
120. Greenfield LJ, Cho KJ, Proctor MC, et al. Late results of suprarenal Greenfield vena caval filter placement. Arch Surg. 1992; 127: 969-973.
122. Matchett WJ, Jones MP, McFarland DR, Ferris EJ. Suprarenal vena caval filter placement: follow-up of four filter types in 22 patients. J Vasc Intervent Radiol. 1998; 9(4): 588-593.
123.
123. Marcy PY, Magne N, Frenay M, Bruneton JN. Renal failure secondary to thrombotic complications of suprarenal inferior vena cava filter in cancer patients. Cardiovasc Intervent Radiol. 2001; 24(4): 257-259.
124.
124. Lidagoster MI, Widman WD, Chevinski AH. Superior vena caval occlusion after filter insertion. J Vasc Surg. 1994; 20: 158-159.
125.
125. Pais SO, Orchis DF, Mirvis SE. Superior vena caval placement of Kimray-Greenfield filter. Radiology. 1987; 165: 385-386.
126.
126. Owen EW Jr, Schoettle GP Jr, Harrington OB. Placement of a Greenfield filter in the superior vena cava. Ann Thorac Surg. 1992; 53(5): 896-897.
127.
127. Ascer E, Gennaro M, Lorensen E, Pollina RM. Superior vena caval Greenfield filters: indications, techniques, and results. J Vasc Surg. 1996; 23(3): 498-503.
128.
128. Ascer E, Hingorani A, Tsemekhin B, Yorkovich W, Gunduz Y. Lessons learned from a 6 year clinical experience with superior vena cava Greenfield filters. J Vasc Surg. 2000; 32(5): 881-887.
129.
129. Monreal M, Lafoz E, Ruiz J, Valls R, Alastrue A. Upper-extremity deep venous thrombosis and pulmonary embolism. A prospective study. Chest. 1991; 99(2): 280-283.
130.
130. Hingorani A, Ascher E, Lorenson E, et al. Upper extremity deep venous thrombosis and its impact on morbidity and mortality rates in a hospital-based population. J Vasc Surg. 1997; 26(5): 853-860.
131.
131. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994; 331: 1601-1606.
132.
132. Sevitt S, Gallagher, N. Venous thrombosis and pulmonary embolism: a clinico-pathological study in injured and burned patients. Br J Surg. 1961; 48: 475-489.
133.
133. Webb LX, Rush PT, Fuller SB, Meredith JW. Greenfield filter prophylaxis of pulmonary embolism in patients undergoing surgery for acetabular fracture. J Orthoped Trauma. 1992; 6(2): 139-145.
134.
134. Rogers FB, Shackford SR, Wilson J, Ricci MA, Morris CS. Prophylactic vena cava filter insertion in severely injured trauma patients: indications and preliminary results. J Trauma. 1993; 35(4): 637-641.
135.
135. Leach TA, Pastena JA, Swan KG, Tikellis JI, Blackwood JM, Odom JW. Surgical prophylaxis for pulmonary embolism. Am Surg. 1994; 60(4): 292-295.
136.
136. Rosenthal D, McKinsey JF, Levy AM, Lamis PA, Clark MD. Use of the Greenfield filter in patients with major trauma. Cardiovasc Surg. 1994; 2(1): 52-55.
137.
137. Wilson JT, Rogers FB, Wald SL, Shackford SR, Ricci MA. Prophylactic vena cava filter insertion in patients with traumatic spinal cord injury: preliminary results. Neurosurgery. 1994; 35(2): 234-239.
138.
138. Winchell RJ, Hoyt DB, Walsh JC, Simons RK, Eastman AB. Risk factors associated with pulmonary embolism despite routine prophylaxis: implications for improved protection. J Trauma. 1994; 37(4): 600-606.
139.
139. Khansarinia S, Dennis JW, Veldenz HC, Butcher JL, Hartland L. Prophylactic Greenfield filter placement in selected high-risk trauma patients. J Vasc Surg. 1995; 22(3): 231-235.
140.
140. Rogers FB, Shackford SR, Ricci MA, Wilson JT, Parsons S. Routine prophylactic vena cava filter insertion in severely injured trauma patients decreases the incidence of pulmonary embolism. J Am Coll Surg. 1995; 180: 641-647.
141.
141. Zolfaghari D, Johnson B, Weireter LJ, Britt LD. Expanded use of inferior vena cava filters in the trauma population. Surg Annu. 1995; 27: 99-105.
143. Rodriguez JL, Lopez JM, Proctor MC, et al. Early placement of prophylactic vena caval filters in injured patients at high risk for pulmonary embolism. J Trauma. 1996; 40(5): 797-802.
144.
144. Gosin JS, Graham AM, Ciocca RG, Hammond JS. Efficacy of prophylactic vena cava filters in high-risk trauma patients. Ann Vasc Surg. 1997; 11(1): 100-105.
146. Rogers FB, Strindberg G, Shackford SR, et al. Five-year follow-up of prophylactic vena cava filters in high-risk trauma patients. Arch Surg. 1998; 133: 406-411.
147.
147. Greenfield LJ, Proctor MC, Michaels AJ, Taheri PA. Prophylactic vena caval filters in trauma: the rest of the story. J Vasc Surg. 2000; 32(3): 490-497.
148.
148. Wojcik R, Cippolle MD, Fearen I, Jaffe J, Newcomb J, Pasquale MD. Long-term follow up of trauma patients with a vena caval filter. J Trauma. 2000; 49(5): 839-843.
149.
149. Sekharan J, Dennis JW, Miranda FE, et al. Long-term followup of prophylactic Greenfield filters in multisystem trauma patients. J Trauma. 2001; 51(6): 1087-1090.
150.
150. Geerts WH, Jay RM, Code KI, et al. A comparison of lowdose heparin with low-molecular weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med. 1996; 335: 701-707.
151.
151. Norwood SH, McAuley CE, Berne JD, et al. A potentially expanded role for enoxaparin in preventing venous thromboembolism in high risk blunt trauma patients. J Am Coll Surg. 2001; 192(2): 161-167.
152.
152. Knudson MM, Morabito D, Paiement GD, Shackleford S. Use of low molecular weight heparin in preventing thromboembolism in trauma patients. J Trauma. 1996; 41(3): 446-459.
153.
153. Headrick JR, Barker DE, Pate LM, Horne K, Russell WL, Burns RP. The role of ultrasonography and inferior vena cava filter placement in high-risk trauma patients. Am Surg. 1997; 63: 1-8.
154.
154. Spain DA, Richardson JD, Polk HC Jr, Bergamini TM, Wilson MA, Miller FB. Venous thromboembolism in the high-risk trauma patient: do risks justify aggressive screening and prophylaxis? J Trauma. 1997; 42(3): 463-467.
155.
155. Tuttle-Newhall JE, Rutledge R, Hultman CS, Fakhry SM. Statewide, population-based, time-series analysis of the frequency and outcome of pulmonary embolus in 318, 554 trauma patients [see Comments]. J Trauma. 1997; 42(1): 90-99.
156.
156. Velmahos GC, Kern J, Chan LS, Oder D, Murray JA, Shekelle P. Prevention of venous thromboembolism after injury: an evidence-based report—Part I: analysis of risk factors and evaluation of the role of vena caval filters. J Trauma. 2000; 49(1): 132-139.
157.
157. Velmahos GC, Kern J, Chan LS, Oder D, Murray JA, Shekelle P. Prevention of venous thromboembolism after injury: an evidence-based report—Part II: analysis of risk factors and evaluation of the role of vena caval filters. J Trauma. 2000; 49(1): 140-144.
158.
158. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest. 2001; 119(1 Suppl): 132S-175S.
159.
159. Patterson BM, Marchand R, Ranawat C. Complications of heparin therapy after total joint arthroplasty. J Bone Joint Surg Am. 1989; 71(8): 1130-1134.
160.
160. Vaughn BK, Knezevich S, Lombardi AV Jr, Mallory TH. Use of the Greenfield filter to prevent fatal pulmonary embolism associated with total hip and knee arthroplasty. J Bone Joint Surg [Am]. 1989; 71(10): 1542-1548.
161.
161. Emerson RH Jr, Cross R, Head WC. Prophylactic and early therapeutic use of the Greenfield filter in hip and knee joint arthroplasty. J Arthroplasty. 1991; 6(2): 129-135.
162.
162. Bicalho PS, Hozack WJ, Rothman RH, Eng K. Treatment of early symptomatic pulmonary embolism after total joint arthroplasty. J Arthroplasty. 1996; 11(5): 522-524.
163.
163. Woolson ST, Harris WH. Greenfield vena caval filter for management of selected cases of venous thromboembolic disease following hip surgery. Clin Orthoped Rel Res. 1986; 204: 201-206.
164.
164. Hillen HF. Thrombosis in cancer patients. Ann Oncol. 2000; 11(Suppl 3): 273-276.
165.
165. Moore FD Jr, Osteen RT, Karp DD, Wilson RE. Anticoagulants, venous thromboembolism and the cancer patient. Arch Surg. 1981; 116: 405-407.
166.
166. Clarke-Pearson DL, Synan IS, Creasman WT. Anticoagulation therapy for venous thromboembolism in patients with gynecologic malignancy. Am J Obstet Gynecol. 1983; 147(4): 369-375.
167.
167. Cohen JR, Tenenbaum N, Citron M. Greenfield filter as primary therapy for deep venous thrombosis and/or pulmonary embolism in patients with cancer. Surgery. 1991; 109(1): 12-15.
168.
168. Cantelmo NL, Menzoian JO, Logerfo FW, Fasulo G, Mozden PJ. Clinical experience with vena caval filters in high-risk cancer patients. Cancer. 1982; 50(2): 341-344.
169.
169. Walsh DB, Downing S, Nauta R, Gomes MN. Metastatic cancer: a relative contraindication to vena caval filter placement. Cancer. 1987; 59: 161-163.
170.
170. Whitney BA, Kerstein MD. Thrombocytopenia and cancer: use of the Kim-Ray Greenfield filter to prevent thromboembolism. South Med J. 1987; 80(10): 1246-1248.
171.
171. Muchmore JH, Dunlap JN, Culicchia F, Kerstein MD. Deep vein thrombophlebitis and pulmonary embolism in patients with malignant gliomas. South Med J. 1989; 82(11): 1352-1356.
172.
172. Hubbard KP, Roehm JO Jr, Abbruzzese JL. The bird’s nest filter. An alternative to long-term oral anticoagulation in patients with advanced malignancies. Am J Clin Oncol. 1994; 17(2): 115-117.
173.
173. Cohen JR, Grella L, Citron M. Greenfield filter instead of heparin as primary treatment for deep venous thrombosis or pulmonary embolism in patients with cancer. Cancer. 1992; 70(7): 1993-1996.
174.
174. Rosen MP, Porter DH, Kim D. Reassessment of vena caval filter use in patients with cancer. J Vasc Intervent Radiol. 1994; 5(3): 501-506.
176. Schwarz RE, Marrero AM, Conlon KC, Burt M. Inferior vena cava filters in cancer patients: indications and outcome. J Clin Oncol. 1996; 14(2): 652-657.
177.
177. Greenfield LJ, Proctor MC, Saluja A. Clinical results of Greenfield filter use in patients with cancer. Cardiovasc Surg. 1997; 5(2): 145-149.
178.
178. Olin JW, Young JR, Graor RA, et al. Treatment of deep vein thrombosis and pulmonary emboli in patients with primary and metastatic brain tumors. Arch Int Med. 1987; 147: 2177-2179.
179.
179. Calligaro KD, Bergen WS, Haut MJ, Savarese RP, DeLaurentis DA. Thromboembolic complications in patients with advanced cancer: anticoagulation versus Greenfield filter placement. Ann Vasc Surg. 1991; 5(2): 186-189.
180.
180. Levin JM, Schiff D, Loeffler JS, et al. Complications of therapy for venous thromboembolic disease in patients with brain tumors. Neurology. 1993; 43: 1111-1114.
181.
181. Schiff D, DeAngelis LM. Therapy of venous thromboembolism in patients with brain metastases. Cancer. 1994; 73(2): 493-498.
182.
182. Ihnat DM, Mills JL, Hughes JD, Gentile AT, Berman SS, Westerband A. Treatment of patients with venous thromboembolism and malignant disease: should vena cava filter placement be routine? J Vasc Surg. 1998; 28(5): 800-807.
183.
183. Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JG, Buller HR. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol. 2000; 18(17): 3078-3083.
184.
184. Norris CS, Greenfield LJ, Herrmann JB. Free-floating iliofemoral thrombus: a risk of pulmonary embolism. Arch Surg. 1985; 120: 806-808.
185.
185. Berry RE, George JE, Shaver WA. Free-floating thrombus: a retrospective analysis. Ann Surg. 1990; 211: 719-723.
186.
186. Monreal M, Ruiz J, Salvador R, et al. Recurrent pulmonary embolism: a prospective study. Chest. 1989; 95: 976-979.
187.
187. Baldridge ED, Martin MA, Welling RE. Clinical significance of free-floating venous thrombi. J Vasc Surg. 1990; 11: 62-69.
188.
188. Radomski JS, Jarrell BE, Carabasi RA, Yang S-L, Koolpe H. Risk of pulmonary embolus with inferior vena cava thrombosis. Am Surg. 1987; 53: 97-101.
189.
189. Pacouret G, Alison D, Pottier J-M, et al. Free-floating thrombus and embolic risk in patients with angiographically confirmed proximal deep venous thrombosis: a prospective study. Arch Int Med. 1997; 157: 305-308.
190.
190. Prandoni P, Lensing AWA, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996; 125: 1-7.
191.
191. Eichlisberger R, Widmer MT, Frauchiger B, Widmer LK, Jager K. [The incidence of post-thrombotic syndrome]. Wien Med Wochenschr. 1994; 144(10-11): 192-195.
192.
192. Rogers LQ, Lutcher CL. Streptokinase therapy for deep vein thrombosis: a comprehensive review of the English literature. Am J Med. 1990; 88(4): 389-395.
194. Martin M, Eickerling B. Todliche Lungenembolie Unter Ultrahoch-Dosierter Streptokinase-Behandlung. Dtsch Med Wochenschr. 1990; 115(47): 1812.
195.
195. Grimm W, Schwieder G, Wagner T. [Fatal pulmonary embolism in venous thrombosis of the leg and pelvis during lysis therapy]. Dtsch Med Wochenschr. 1990; 115(31-32): 1183-1187.
196.
196. Bjarnason H, Yedlicka JW Jr, Hunter DW, Castaneda-Zuniga WR, Amplatz K. In vitro metal fatigue testing of inferior vena cava filters. Invest Radiol. 1994; 29(9): 817-821.
197.
197. Semba CP, Dake MD. Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis. Radiology. 1994; 191(2): 487-494.
198.
198. Millward SF. Temporary and retrievable inferior vena cava filters: current status. J Vasc Intervent Radiol. 1998; 9: 381-387.
199.
199. Thery C, Bauchart JJ, Lesenne M, et al. Predictive factors of effectiveness of streptokinase in deep venous thrombosis. Am J Cardiol. 1992; 69(1): 117-122.
200.
200. Lorch H, Welger D, Wagner V, et al. Current practice of temporary vena cava filter insertion: a multicenter registry. J Vasc Intervent Radiol. 2000; 11(1): 83-88.
201.
201. Nutting C, Coldwell D. Use of a TrapEase device as a temporary caval filter. J Vasc Intervent Radiol. 2001; 12(8): 991-993.
202.
202. Tracy T Jr, Posner MP, Drucker DE, et al. Use of the Greenfield filter in adolescents for deep vein thrombosis and pulmonary embolism. J Pediatr Surg. 1988; 23(6): 529-532.
203.
203. Reed RA, Teitelbaum GP, Stanley P, Mazer MJ, Tonkin IL, Rollins NK. The use of inferior vena cava filters in pediatric patients for pulmonary embolus prophylaxis. Cardiovasc Intervent Radiol. 1996; 19(6): 401-405.
205. Comp PC, Thurnau GR, Welsh J, Esmon CT. Functional and immunologic protein S levels are decreased during pregnancy. Blood. 1986; 68(4): 881-885.
206.
206. Stirling Y, Woolf L, North WR, Seghatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemost. 1984; 52(2): 176-182.
207.
207. Cerneca F, Ricci G, Simeone R, Malisano M, Alberico S, Guaschino S. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Reprod Biol. 1997; 73(1): 31-36.
208.
208. Kerr MG, Scott DB, Samuel E. Studies of the inferior vena cava in late pregnancy. Br Med J. 1964; 1: 532-533.
209.
209. Aburahma AF, Mullins DA. Endovascular caval interruption in pregnant patients with deep vein thrombosis of the lower extremity. J Vasc Surg. 2001; 33(2): 375-378.
210.
210. Arbogast JD, Blessed WB, Lacoste H, Gross WS, Gonda RL Jr, Welch RA. Use of two Greenfield caval filters to prevent recurrent pulmonary embolism in a heparin-allergic gravida. Obstet Gynecol. 1994; 84(4 Pt 2): 652-654.
211.
211. Banfield PJ, Pittam M, Marwood R. Recurrent pulmonary embolism in pregnancy managed with the Greenfield vena caval filter. Int J Gynaecol Obstet. 1990; 33(3): 275-278.
212.
212. Scurr J, Stannard P, Wright J. Extensive thromboembolic disease in pregnancy treated with a Kimray-Greenfield vena cava filter. Br J Obstet Gynaecol. 1981; 88: 778-780.
213.
213. Zwaan M, Lorch H, Kulke C, et al. Clinical experience with temporary vena caval filters. J Vasc Interv Radiol. 1998; 9(4): 594-601.
214.
214. Ponchon M, Gofette P, Hainaut P. Temporary vena caval filtration: preliminary clinical experience with removable vena caval filters. Acta Clin Belg. 1999; 54(5): 223-228.
215.
215. Neill AM, Appleton DS, Richards P. Retrievable inferior vena caval filter for thromboembolic disease in pregnancy [see Comments]. Br J Obstet Gynaecol. 1997; 104(12): 1416-1418.
216.
216. Still J, Friedman B, Furman S, Cohen H, Gates C, Dawson J, Law E. Experience with the insertion of vena caval filters in acutely burned patients. Am Surg. 2000; 66(3): 277-279.
217.
217. Walker HS III, Pennington DG. Inferior vena caval filters in heart transplant recipients with perioperative deep vein thromboses. J Heart Transplant. 1990; 9(5): 579-580.
218.
218. Jamieson SW, Nomura K. Indications for and the results of pulmonary thromboendarterectomy for thromboembolic pulmonary hypertension. Semin Vasc Surg. 2000; 13(3): 236-244.
219.
219. Mo M, Kapelanski DP, Mitruka SN, et al. Reoperative pulmonary thromboendarterectomy. Ann Thorac Surg. 1999; 68(5): 1770-1776.
220.
220. Bovyn G, Gory P, Reynaud P, Ricco JB. The tempofilter: a multicenter study of a new temporary caval filter implantable for up to six weeks. Ann Vasc Surg. 1997; 11(5): 520-528.
221.
221. Rossi P, Arata FM, Bonaiuti P, Pedicini V. Fatal outcome in atrial migration of the tempofilter. Cardiovasc Intervent Radiol. 1999; 22(3): 227-231.
222.
222. Kelly IM, Boyd CS. Buckling of the tethering catheter causes migration of a temporary caval filter to the right atrium. Clin Radiol. 1999; 54(6): 398-401.
223.
223. Vos LD, Tielbeek AV, Bom EP, Gooszen HC, Vroegindeweij D. The Gunther temporary inferior vena cava filter for short-term protection against pulmonary embolism. Cardiovasc Intervent Radiol. 1997; 20(2): 91-97.
224.
224. Linsenmaier U, Rieger J, Schenk F, Rock C, Mangel E, Pfeifer KJ. Indications, management, and complications of temporary inferior vena cava filters. Cardiovasc Intervent Radiol. 1998; 21(6): 464-469.
225.
225. Millward SF, Bhargava A, Aquino J Jr, et al. Gunther tulip filter: preliminary clinical experience with retrieval. J Vasc Interv Radiol. 2000; 11(1): 75-82.
226.
226. Millward SF, Oliva VL, Bell SD, et al. Gunther tulip retrievable vena cava filter: results from the registry of the Canadian Interventional Radiology Association. J Vasc Intervent Radiol. 2001; 12(9): 1053-1058.
227.
227. Neuerburg JM, Gunther RW, Vorwerk D, et al. Results of a multicenter study of the retrievable tulip vena cava filter: early clinical experience. Cardiovasc Intervent Radiol. 1997; 20(1): 10-16.
228.
228. Nunn CR, Neuzil D, Naslund T, et al. Cost-effective method for bedside insertion of vena caval filters in trauma patients [see Comments]. J Trauma. 1997; 43(5): 752-758.
230. Sato DT, Robinson KD, Gregory RT, et al. Duplex directed caval filter insertion in multi-trauma and critically ill patients. Ann Vasc Surg. 1999; 13(4): 365-371.
231.
231. Benjamin ME, Sandager GP, Cohn EJ Jr, et al. Duplex ultrasound insertion of inferior vena cava filters in multitrauma patients. Am J Surg. 1999; 178(2): 92-97.
232.
232. Sing RF, Smith CH, Miles WS, Messick WJ. Preliminary results of bedside inferior vena cava filter placement: safe and cost-effective [see Comments]. Chest. 1998; 114(1): 315-316.
233.
233. Sing RF, Stackhouse DJ, Jacobs DG, Heniford BT. Safety and accuracy of bedside carbon dioxide cavography for insertion of inferior vena cava filters in the intensive care unit. J Am Coll Surg. 2001; 192(2): 168-171.
235. Sing RF, Jacobs DG, Heniford BT. Bedside insertion of inferior vena cava filters in the intensive care unit. J Am Coll Surg. 2001; 192(5): 570-575.
236.
236. Dewald CL, Jensen CC, Park YH, et al. Vena cavography With CO(2) versus with iodinated contrast material for inferior vena cava filter placement: a prospective evaluation. Radiology. 2000; 216(3): 752-757.
238. Ashley DW, Gamblin TC, Burch ST, Solis MM. Accurate deployment of vena cava filters: comparison of intravascular ultrasound and contrast venography. J Trauma. 2001; 50(6): 975-981.
239.
239. Stein PD, Hull RD, Raskob GE. Withholding treatment in patients with acute pulmonary embolism who have a high risk of bleeding and negative serial noninvasive leg tests. Am J Med. 2000; 109: 301-306.
240.
240. Kearon C, Gent M, Hirsh J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med. 1999; 340(12): 901-907.
241.
241. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GR. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med. 1995; 332(15): 993-997.
242.
242. Falanga A, Rickles FR. Pathophysiology of the thrombophilic state in the cancer patient. Semin Thromb Hemostat. 1999; 25(2): 173-182.
